SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe

← ETF Screener

THNR Amplify Weight Loss Drug & Treatment ETF

Issuer
Amplify
Inception
May 21, 2024
AUM
$5.2M
Expense ratio
0.59%
Yield
—
Asset class
Equity
Holdings
20
Last price
$25.84

The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.

No price history on file.

Performance

1M3MYTD1Y3Y ann.5Y ann.
THNR——————
Equity average (4726 funds)-2.6%-5.1%+7169.5%+4568.0%+16.3%+3.4%

Insider activity in the holdings

Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$0 net.

No open-market insider buys in the holdings in the last 90 days.

Holdings · as of Nov 13, 2026

#HoldingWeight
1LLY Eli Lilly & Co11.98%
2NVO Novo Nordisk A/S8.71%
3AMGN Amgen Inc6.14%
4REGN Regeneron Pharmaceuticals Inc6.04%
5AZN AstraZeneca PLC5.81%
6ROP.SW Roche Holding AG5.74%
7GILD Gilead Sciences Inc5.67%
8ABBV AbbVie Inc5.65%
9PFE Pfizer Inc5.24%
104519.T Chugai Pharmaceutical Co Ltd5.16%
11MRK Merck & Co Inc4.97%
121093.HK CSPC Pharmaceutical Group Ltd4.65%
131801.HK Innovent Biologics Inc4.48%
14VKTX Viking Therapeutics Inc4.20%
15ZEAL.CO Zealand Pharma A/S3.30%
16128940.KS Hanmi Pharm Co Ltd3.26%
17ARWR Arrowhead Pharmaceuticals Inc2.78%
181276.HK Jiangsu Hengrui Pharmaceuticals Co Ltd2.30%
19GPCR Structure Therapeutics Inc2.02%
20KLRA Kailera Therapeutics Inc1.10%
21AGPXX Invesco Government & Agency Portfolio 12/31/20310.48%
22THNR Cash & Other0.33%

Sector breakdown

Not on file.

Country breakdown

Not on file.

Distributions

No distributions on file.

Members of Congress who disclosed this ETF

No member of Congress has disclosed a trade in THNR in the filings we hold.

Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 19, 2026. This is historical data, not investment advice. Report a data error